(S)-2-(Trifluoromethyl)morpholine hydrochloride

Catalog No. :
ACBPVO168
CAS No. :
1394909-69-3
Molecular Formula :
C5H9ClF3NO
Molecular Weight :
191.58

IUPAC Name:(S)-2-(trifluoromethyl)morpholine hydrochloride

(S)-2-(Trifluoromethyl)morpholine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$128.00Login to see priceIn stockIn stock
250mg95%$231.00Login to see priceIn stockIn stock
1g95%$537.00Login to see priceIn stockInquiry
5g95%$1781.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(Trifluoromethyl)morpholine hydrochloride
IUPAC Name(S)-2-(trifluoromethyl)morpholine hydrochloride
MDL No.MFCD24621417
Molecular FormulaC5H9ClF3NO
Molecular Weight191.58
SMILESFC([C@@H]1CNCCO1)(F)F.[H]Cl
InChI KeyINIKTCFEWCCJMM-WCCKRBBISA-N
Synonym(2S)-2-(trifluoromethyl)morpholine;hydrochloride | CS-0102290 | AS-84201 | AKOS027469851 | (2S)-2-(trifluoromethyl)morpholine hydrochloride | (2S)-2-(trifluoromethyl)morpholinehydrochloride | (S)-2-(Trifluoromethyl)morpholine hydrochloride | EN300-1270239
CAS No.1394909-69-3
PubChem CID68285203

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBPVO168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBPVO168 route product structure diagram
    ACBPVO1681394909-69-3 In Stock
Inquiry

2. ACBPVO168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBPVO168 route product structure diagram
    ACBPVO1681394909-69-3 In Stock
Inquiry

Comments (0)